Telomerase extends telomeres by acting as a specialized reverse transcriptase: it carries its own RNA template and uses it to build new DNA repeats directly onto chromosome ends. Each time a cell divides, the natural copying machinery leaves a small stretch of the chromosome tip unreplicated, gradually whittling telomeres down. Telomerase counteracts that erosion by repeatedly adding short DNA sequences, six nucleotides at a time in humans, to the very tips of chromosomes. The process is more tightly regulated, and more structurally intricate, than a simple “add DNA here” description suggests.
Why Telomeres Need Help in the First Place
Every chromosome in your cells ends in a repetitive stretch of DNA called a telomere. In humans, the repeating unit is TTAGGG, and thousands of these repeats cap each chromosome end. Telomeres exist because the cell’s standard DNA-copying machinery cannot fully replicate the very tip of a linear chromosome. This is known as the end replication problem: each round of cell division leaves a small segment at the 3′ end uncopied, so the telomere gets a little shorter every time the cell divides.1PubMed Central. Telomere Replication: Solving Multiple End Replication Problems If nothing restores that lost DNA, telomeres eventually become too short to protect the chromosome. At that point, the cell treats the exposed chromosome end as damaged DNA and either stops dividing permanently or dies. This growth arrest is called cellular senescence, and it sets a built-in limit on how many times most cells can divide.2PubMed. The Connection Between Cell Fate and Telomere
What Telomerase Is Made Of
Telomerase is not a single protein. It is a complex built from both protein and RNA components, making it what biologists call a ribonucleoprotein. The two core pieces are the catalytic protein subunit, called TERT (telomerase reverse transcriptase), and an RNA molecule called TR or TER (telomerase RNA).3PubMed Central. It all comes together at the ends: telomerase structure, function, and biogenesis TERT is the part that actually builds new DNA. TR provides the template, a short internal sequence that telomerase reads to know which nucleotides to add. In humans, that template directs the synthesis of the TTAGGG repeat.4Cell. Structure of Tetrahymena Telomerase with Bound Telomeric DNA
Beyond the core two, the human telomerase holoenzyme (the full working assembly) includes additional proteins. Structural studies using cryo-electron microscopy have revealed that the complete human complex has two loosely connected lobes joined by the RNA. One lobe contains TERT and the active site. The other is an H/ACA ribonucleoprotein lobe made up of several accessory proteins, including one called TCAB1 that helps route telomerase to the right location inside the nucleus.5PubMed Central. Cryo-EM structure of substrate-bound human telomerase holoenzyme These accessory proteins do not directly synthesize DNA, but without them, the complex fails to assemble properly or never reaches the chromosome tips where it is needed.
The Extension Cycle, Step by Step
Telomerase works by a mechanism that is the reverse of what most DNA-copying enzymes do. Normally, cells read a DNA template to build DNA. Telomerase reads its own RNA template to build DNA, which is why it is classified as a reverse transcriptase.6PubMed Central. Composition and Function of Telomerase-A Polymerase Associated with the Origin of Eukaryotes The process plays out in a repeating cycle:
- Binding: The single-stranded overhang at the chromosome tip (the 3′ end) slots into telomerase’s active site, base-pairing with the RNA template inside the enzyme.
- Extension: TERT uses the RNA template to add nucleotides one at a time to the chromosome end, synthesizing one TTAGGG repeat.
- Translocation: Once a full repeat has been added, the enzyme shifts (translocates) along the newly made DNA so that the template can be reused. The fresh DNA moves out of the active site, and the template realigns to direct another round of synthesis.
- Repeat: The cycle starts again, adding another six-nucleotide unit. Under laboratory conditions, human telomerase can add dozens of repeats in a row before letting go of the chromosome.
Early biochemical work on a human telomerase activity showed that the enzyme could synthesize 65 to 70 TTAGGG repeats onto a primer under optimal conditions, confirming both the repeating pattern and the enzyme’s capacity for sustained extension.7Cell. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats After telomerase finishes, other enzymes fill in the complementary strand to complete the double-stranded portion, but the very tip always retains a short single-stranded overhang ready for the next round.
How the Cell Controls Telomerase Access
If telomerase extended telomeres constantly and without limit, cells could divide indefinitely, which is exactly what you see in cancer. Healthy cells keep telomerase on a tight leash through multiple layers of regulation.
The first layer is expression. In most adult human tissues, the gene encoding TERT is simply turned off. Without TERT protein, telomerase cannot function, and telomeres shorten with each division. The exceptions are stem cells (which need to divide many times over a lifetime) and certain immune cells. In those compartments, telomerase activity is detectable, and stem cells tend to have the longest telomeres within a given tissue.8PubMed. Telomeres and telomerase in adult stem cells and pluripotent embryonic stem cells Even in stem cells, though, telomerase does not fully prevent shortening over a lifetime. It slows the erosion rather than eliminating it.9PubMed Central. Telomere and telomerase in stem cells
The second layer is physical access. A six-protein complex called shelterin coats the telomere and protects it from being mistaken for broken DNA. Shelterin also regulates whether telomerase can reach the chromosome end at all.10PubMed Central. Shelterin Complex at Telomeres: Implications in Ageing Two shelterin components, POT1 and TPP1, play a dual role. Together they reduce open access to the single-stranded overhang,11Nucleic Acids Research. Shelterin reduces the accessibility of telomeric overhangs but paradoxically, the TPP1-POT1 pair is also the complex that physically recruits telomerase to the telomere and boosts its ability to add multiple repeats without falling off (a property called processivity).12PubMed Central. POT1-TPP1 enhances telomerase processivity by slowing primer dissociation and aiding translocation Structural work has mapped the specific contact points between TPP1-POT1 and telomerase, showing that TPP1-POT1 stabilizes the DNA as it exits the active site and anchors the enzyme for its translocation step.13PubMed Central. Structural basis of human telomerase recruitment by TPP1-POT1 So shelterin acts as both a gatekeeper and a guide: it blocks random access but escorts telomerase in when conditions are right.
Timing Matters: Telomerase Works During DNA Replication
Telomerase does not show up at telomeres whenever it pleases. In human cells, recruitment happens during S phase, the part of the cell cycle when the entire genome is being copied.14PubMed Central. Live Cell Imaging Reveals the Dynamics of Telomerase Recruitment to Telomeres This timing makes biological sense: the end replication problem only manifests during DNA replication, so that is exactly when repair is needed. Work in yeast has further shown that effective telomere lengthening depends on the stable accumulation of multiple telomerase complexes at the chromosome tip during late S phase, and that this timing is actively regulated by specific proteins.15PubMed Central. A date with telomerase: pick you up at S phase
There is also a preference for the shortest telomeres. Cells do not extend every chromosome equally. Instead, the telomeres that have eroded the most tend to be the ones that get the most telomerase attention. This preferential extension of short telomeres helps maintain a relatively uniform telomere length across the genome, preventing any single chromosome from becoming dangerously exposed.
G-Quadruplexes and the Obstacles Telomerase Must Navigate
The G-rich single-stranded overhang at the telomere tip is not simply a floppy strand of DNA. These sequences can fold into compact structures called G-quadruplexes, four-stranded knots held together by unusual bonding between guanine bases. Because telomerase needs to bind a single strand of DNA to do its work, these folded structures might seem like they would block extension entirely. Yet experiments show that human telomerase can extend even stable parallel G-quadruplex structures, unfolding them as part of the extension process.16eLife. A mechanism for the extension and unfolding of parallel telomeric G-quadruplexes by human telomerase at single-molecule resolution The ability to deal with these structures is relevant because G-quadruplexes also affect telomere maintenance in cancer cells, and drugs that stabilize G-quadruplexes are being explored as a way to interfere with telomerase.
Cancer Cells Hijack Telomerase
The tight silencing of TERT in adult cells is one of the body’s main defenses against uncontrolled growth. For a cell to become cancerous and divide without limit, it needs a way to maintain its telomeres. The most common route is to reactivate telomerase. Mutations in the TERT gene’s promoter region, the stretch of DNA that controls when and how much TERT protein is made, are among the most common noncoding mutations found across cancers. These mutations have been identified in more than 50 cancer types.17PubMed Central. Understanding TERT Promoter Mutations: A Common Path to Immortality They work by creating new binding sites for transcription factors, effectively flipping the TERT gene back on and allowing cancer cells to produce telomerase again.18Genes & Development. Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers
A smaller subset of cancers, roughly 5 to 10 percent, bypass telomerase altogether and use a completely different strategy called ALT (alternative lengthening of telomeres). ALT relies on a DNA repair process similar to break-induced replication, where one telomere uses another as a copying template. The hallmark of ALT tumors is dramatic variation in telomere length from cell to cell, along with widespread chromosomal instability.19Journal of Clinical Pathology. Alternative lengthening of telomeres: mechanism and the pathogenesis of cancer The existence of ALT is one reason why simply blocking telomerase is not a universal cancer cure: some tumors have a built-in backup.
Because telomerase activity correlates with tumor progression, researchers have explored it as a biomarker for early cancer detection. Assays that measure telomerase activity in tissue samples can flag aggressive tumors, and the idea of screening for elevated telomerase has been studied as a potential diagnostic tool.20PubMed Central. Analytical validation of telomerase activity for cancer early detection
When Telomerase Itself Is Broken
If cancer represents too much telomerase, a group of inherited conditions called telomere biology disorders (sometimes called telomeropathies) represent too little. These are caused by mutations in genes encoding telomerase components or telomere-associated proteins. Mutations in TERT, TERC (the gene for telomerase RNA), and several other genes have been identified in these patients, with a causal mutation found in roughly half to 60 percent of affected individuals.21PubMed Central. The genetics and clinical manifestations of telomere biology disorders The result is abnormally short telomeres from an early age, leading to premature failure of rapidly dividing tissues. The classic presentation, a condition called dyskeratosis congenita, involves bone marrow failure, abnormal skin pigmentation, and nail dystrophy, but the spectrum is wide and can include lung fibrosis and liver disease.
Drugs That Target Telomerase
Understanding how telomerase works has led to drugs aimed at either blocking it or boosting it, depending on the disease context. On the inhibition side, imetelstat is a first-in-class telomerase inhibitor designed to compete directly with telomere DNA for the active site of the enzyme. By blocking telomerase, imetelstat selectively triggers death of malignant cells that depend on the enzyme, allowing normal blood cell production to recover.22PubMed Central. Imetelstat: A First-in-Class Telomerase Inhibitor for the Treatment of Patients With Lower-Risk Myelodysplastic Syndromes and Anemia It has been studied in blood cancers where abnormal clones rely on telomerase to sustain themselves.
On the activation side, a compound called TA-65, derived from the root of the plant Astragalus membranaceus, has been studied in mice for its ability to increase telomerase activity. In mouse cells that had critically short telomeres but still carried one working copy of the telomerase RNA gene, TA-65 increased average telomere length and reduced the percentage of the shortest telomeres. Crucially, the same treatment had no effect in cells completely lacking telomerase, confirming that TA-65 works through the telomerase pathway rather than some other mechanism.23PubMed Central. The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence TA-65 is marketed as a supplement, but the leap from mouse cell experiments to meaningful clinical benefits in humans remains unproven, and its long-term safety profile is not established. The concern is straightforward: anything that boosts telomerase could theoretically help early cancer cells survive.
TERT Has a Side Job Outside Telomeres
For years, researchers assumed TERT’s only role was adding DNA to chromosome ends. That assumption has been steadily dismantled. TERT turns up inside mitochondria, the energy-producing compartments of the cell, where it binds mitochondrial DNA and appears to influence mitochondrial replication and gene activity, all without needing its RNA partner TERC.24PLOS Genetics. TERT translocation to mitochondria: Exploring its role in mitochondrial homeostasis Research over nearly two decades has linked TERT to a broad set of non-telomere functions including protection against oxidative damage, regulation of gene expression, and promotion of cell growth through signaling pathways.25PubMed Central. Non-canonical Roles of Telomerase: Unraveling the Imbroglio In neurons, for example, TERT seems to offer protection against reactive oxygen species, those byproducts of energy metabolism that damage cells over time.
These non-canonical roles complicate the picture for anyone trying to target telomerase therapeutically. Blocking TERT to fight cancer could have unintended consequences in mitochondria or stress-response pathways, and boosting TERT for its protective effects could have consequences at telomeres. The dual nature of the protein is an active area of research, and it means the question “what does telomerase do?” has a wider answer than the textbooks of 20 years ago would suggest.26PubMed. Non-canonical Functions of Telomerase Reverse Transcriptase: Emerging Roles and Biological Relevance
Why Larger Animals Tend to Suppress Telomerase
Not all mammals handle telomerase the same way. Small-bodied species like mice have high telomerase activity throughout their tissues and correspondingly long telomeres. Larger species, including humans, suppress telomerase in most adult tissues and have shorter telomeres. The pattern is not a coincidence. Species weighing more than roughly 5 to 10 kilograms tend to repress somatic telomerase activity, and this has been proposed as an evolved anti-cancer mechanism.27PubMed Central. Evolution of telomere maintenance and tumour suppressor mechanisms across mammals A larger body means more cells, and more cells mean more opportunities for a cancer-causing mutation. Shutting down telomerase forces any rogue cell to hit a hard limit on division, making it harder for early tumors to get off the ground.
Reanalysis of telomere data across dozens of mammal species found an inverse relationship between telomere length and both body mass and lifespan: bigger, longer-lived species have shorter telomeres.28PubMed. On the comparative biology of mammalian telomeres: Telomere length co-evolves with body mass, lifespan and cancer risk This finding reinforces the idea that shorter telomeres are not simply a byproduct of aging but an adaptive trait selected for its cancer-suppressive value. The tradeoff is real: it limits regenerative capacity in exchange for better protection against runaway cell growth, a bargain that has evidently paid off for species that live long enough for cancer to be a meaningful threat.